Search Results
Jan 15, 2026, 09:50 ET New Major Study Finds Portfolios with TIAA Traditional Annuity Outperformed in Over 90% of Retirement Scenarios
than $5.9 billion in lifetime income to retired clients in 2024ii and has nearly $1.5 trillion in assets under management (as of 09/30/2025)iii.Learn more about
More news about: TIAA Institute
Jan 15, 2026, 09:32 ET MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
initial issuance date. The Series D Warrants are callable at the Company's option following the release of a positive data readout for its Phase 1b Part III clinical trial for DA-1726 via a widely disseminated press release, subject to satisfaction of certain conditions. The Series C Warrants and Series D
More news about: MetaVia, Inc.
Jan 15, 2026, 09:28 ET Seasats Awarded $24M in Department of War APFIT Funding to Accelerate Fielding of its Autonomous Surface Vessels
for critical maritime applications. Over the past year, Seasats has advanced multiple programs with the Navy and USMC, including an $89M SBIR Phase III contract, rapid prototyping activities, and operational demonstrations in both U.S. and allied waters. In addition, the Navy used a Lightfish for a
More news about: Seasats
Jan 15, 2026, 09:02 ET SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
SECuRE trial will continue enrolment into the Cohort Expansion Phase with planned completion of recruitment in 2026. Phase III registrational trial planning ongoing based on data generated to date.SYDNEY, Jan.
More news about: Clarity Pharmaceuticals
Jan 15, 2026, 09:00 ET Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm
effective than defendants had led investors to believe; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: January 16, 2026 Shareholders
More news about: The Gross Law Firm
Jan 15, 2026, 09:00 ET The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of SLM Corporation(SLM) Shareholders
loss mitigation and/or loan modification programs, as well as the overall stability of the Company's private education loan delinquency rates; and (iii) as a result, defendants' public statements made a materially false and misleading impression regarding SLM's business, operations, and prospects at
More news about: The Gross Law Firm
Jan 15, 2026, 09:00 ET DEFT LAWSUIT ALERT: The Gross Law Firm Notifies DeFi Technologies Investors of a Class Action Lawsuit and Upcoming Deadline
treasury companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (iii) as a result of the foregoing issues, the Company was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (iv) accordingly,
More news about: The Gross Law Firm
Jan 15, 2026, 08:33 ET Red Stone Equity Partners Raises Record $1.75 Billion in Affordable Housing Equity in 2025; Surpasses $13 Billion Raised Since Inception
(i) $1.275 billion in proprietary Low-Income Housing Tax Credit ("LIHTC") fund format; (ii) $394.1 million in multi-investor LIHTC fund format; and (iii) $78.7 million of non-LIHTC preservation fund equity. During the year, Company-sponsored investment funds invested in 82 LIHTC properties and three
More news about: Red Stone Equity Partners, LLC
Jan 15, 2026, 08:10 ET PowerHouse Data Centers Executes Hyperscale Lease at PowerHouse Arcola, Advancing Northern Virginia Expansion
Virginia, one of the world's most important data center markets. PowerHouse Arcola's initial development was funded through AREP Strategic Opportunity Fund III, which supports PowerHouse's development of power-secured hyperscale and AI-ready campuses across its national portfolio.
More news about: PowerHouse Data Centers
Jan 15, 2026, 08:00 ET Frontage CDMO Fully Operational GMP Facility is Ready for Your Needs of Clinical Trials and Commercial Production
its new facility opened in May 2025 had completed GMP facility validation in October 2025, and has been fully operational with on-going Clinical Phase III, PPQ batches and small-scale commercial manufacturing. This new facility is dedicated to drug development and clinical & commercial manufacturing
More news about: Frontage Laboratories, Inc.
Jan 15, 2026, 07:10 ET Bitmine Immersion Technologies (BMNR) Announces $200 Million Investment in Beast Industries
Bitmine is supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: BitMine Immersion Technologies, Inc.
Jan 15, 2026, 07:10 ET Bitmine Immersion Technologies (BMNR) Announces $200 Million Investment in Beast Industries
Bitmine is supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETHLAS
More news about: BitMine Immersion Technologies, Inc.
Jan 15, 2026, 07:10 ET Bitmine Immersion Technologies (BMNR) anuncia una inversión de 200 millones de dólares en Beast Industries
Bitmine cuenta con el apoyo de un destacado grupo de inversores institucionales, entre ellos Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversor personal Thomas "Tom" Lee, para apoyar el objetivo de Bitmine de adquirir el 5 % de ETH.
More news about: BitMine Immersion Technologies, Inc.
Jan 15, 2026, 07:00 ET Main Street Announces Preliminary Estimate of Fourth Quarter 2025 Operating Results
not require settlement in cash, (ii) deferred compensation expense or benefit does not result in a net cash impact to Main Street upon settlement and (iii) tax expenses may include (a) excise tax expense, which is not solely attributable to NII, and (b) deferred taxes, which are not payable in the current
More news about: Main Street Capital Corporation
Jan 15, 2026, 07:00 ET Boston Scientific announces agreement to acquire Penumbra, Inc.
Cardiovascular diseases (CVDs) (who.int)iii Penumbra, Inc. (2025). Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results.
More news about: Boston Scientific Corporation
Jan 15, 2026, 06:00 ET TradingBlock Joins Nant Global Finance, Advancing Its Mission to Deliver Professional-Grade Trading Access
uncertainties associated with (i) difficulties in obtaining financing on commercially reasonable terms; (ii) changes in the size and nature of our competition; (iii) loss of one or more key executives or brand ambassadors; and (iv) changes in legal or regulatory requirements in the markets in which we operate. The
More news about: TradingBlock
Jan 15, 2026, 06:00 ET Federal Deregulation Resulted in 36 Million Workers Lacking Heat Protection and 4.8 Million Losing Health Insurance, Abstract Report
billion in overdraft fees, averaging $220-$225 per affected household. Americans lost $939 million to crypto frauds in early 2025. Basel III suspension led to $1.5 trillion in stock buybacks. For businesses, California, New York, Colorado, and Massachusetts filled the federal void with their
More news about: Abstract
Jan 15, 2026, 05:15 ET LUNGevity and Rising Tide Foundation Issue RFA Tackling Lung Cancer's Toughest Challenges: Drug Resistance and Cancer Recurrence
cancer patients. The foundation works toward this objective by fostering partnerships and striving to attract and support the best in Phase I to Phase III clinical trials. The foundation's efforts are focused on the creation of less toxic therapeutic approaches, better disease burden management, earlier
More news about: LUNGevity Foundation
Jan 15, 2026, 02:00 ET Keurig Dr Pepper Launches Offer for JDE Peet's Shares
anticipated timeframe or at all; (ii) risks relating to the ability to realize the anticipated benefits of the proposed acquisition and subsequent spin-off; (iii) risks relating to the receipt of regulatory approvals without unexpected delays or conditions and possibility of regulatory action; (iv) risks relating
More news about: Keurig Dr Pepper
Jan 14, 2026, 23:00 ET JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects209 new integrated projects in 2025 set a new record, with approximately 50% originating from U.S. clientsComplex modalities are WuXi Biologics'
More news about: WuXi Biologics
Jan 14, 2026, 17:39 ET CRWV Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Against CoreWeave, Inc.
that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; and (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue.A series of disclosures revealing the truth resulted
More news about: Robbins LLP
Jan 14, 2026, 17:31 ET House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight
extract, Dermatophagoides pteronyssinus and Dermatophagoides farinae, adsorbed onto aluminum hydroxide. The therapy is currently being evaluated in a Phase III clinical trial.Probelte Pharma's BELTAVAC is a subcutaneous immunotherapy indicated for the treatment of Alternaria mold allergy. Developed
More news about: DelveInsight Business Research, LLP
Jan 14, 2026, 17:02 ET Haivision Announces Results for the Three Months and Full Year Ended October 31, 2025
to certain (i) non-IFRS financial measures, including "EBITDA", and "Adjusted EBITDA", (ii) non-IFRS ratios including "Adjusted EBITDA Margin", and (iii) supplementary financial measures including "Gross Margins" (collectively "non-IFRS measures"). These non-IFRS measures are not recognized measures
More news about: Haivision Systems Inc.
Jan 14, 2026, 16:01 ET BRC Group Holdings, Inc. Reports Third Quarter 2025 Financial Results
statements portion of this press release.(1) Operating Revenues is defined as the sum of (i) service and fees, (ii) interest income – loans, (iii) interest Income - securities lending, (iv) fixed income spread, (v) trading gains attributable to variable interest transactions, and (vi) sales of
More news about: BRC Group Holdings, Inc.
Jan 14, 2026, 13:56 ET Defense Logistics Agency Awards ASRC Federal Up to $2.3 Billion to Manage Chemical and Oil Supply Chain
Logistics Agency (DLA) for supply chain management for its Chemicals and Packaged Petroleum Oils and Lubricants Performance 3rd Generation (ChemPOL III) program. ASRC Federal will manage DLA's ChemPOL commodities, servicing more than 5,000 global U.S. installations as well as allied partners through
More news about: ASRC Federal